OSCR

Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies.

Overview

Authors: Qun Chen1,2, Yu-Tao Yang1,2, Li Cai1,2, Hai-Qing Zhang1,2, Juan Yang1,2
  1. Department of Neurology, The Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
  2. Key Laboratory of Brain Function and Brain Disease Prevention and Treatment of Guizhou Province, Zunyi, China
Journal: Frontiers in cell and developmental biology, volume 14, article 1793636
Dates: received 22 January 2026; accepted 10 April 2026; published online 24 April 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.3389/fcell.2026.1793636 · PMID 42111266 · PMCID PMC13153039 · OpenAlex W7155493605
Open access: gold, a free copy (OpenAlex)
Categories: human (organism), epilepsy (population), cellular / molecular (subfield)
Keywords: epilepsy, pyroptosis, blood–brain barrier, neurons, glial cells, targeted therapy
Topic: Inflammasome and immune disorders (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 94 references in the paper

Abstract

Epilepsy affects millions of individuals worldwide, however, approximately one-third of patients exhibit pharmacoresistance to currently available antiseizure therapies, underscoring an urgent unmet need for novel mechanism-based therapeutic strategies. Pyroptosis, a Gasdermin-mediated proinflammatory cell death, has recently been implicated as a pivotal driver of epileptogenesis and disease progression. This narrative critically evaluates emerging preclinical and clinical evidence linking pyroptotic signaling to epilepsy pathophysiology, with particular attention to cell-type-specific contributions. In astrocytes, GSDMD activation compromises blood–brain barrier (BBB) integrity, an effect mediated by the downregulation of endothelial tight junction proteins. In neurons, activation of the TRPM7/ROS/JAK2/STAT3 pathway drives pyroptosis, a process that also involves the interaction between NLRP3 and mitophagy. Microglial pyroptosis amplifies neuroinflammation, creating a self-perpetuating cycle. Clinically, the caspase-1 inhibitor VX-765 demonstrated favorable safety and preliminary efficacy in a Phase II randomized controlled trial in patients with refractory epilepsy; however, the trial did not meet its primary efficacy endpoint, suggesting that longer treatment durations may be required to assess its therapeutic potential. Preclinically, the GSDMD inhibitor disulfiram shows BBB-protective effects but is limited by off-target hepatotoxicity; conversely, development of the NLRP3 inhibitor MCC950 was discontinued following adverse hepatic findings in early clinical studies. Accumulating evidence also suggests that non-canonical pyroptotic pathways (caspase-4/5/11, GSDME) and PANoptosis, which integrates pyroptosis, apoptosis, and necroptosis, play a role in epileptic neuronal death. Major translational hurdles poor CNS bioavailability of candidate inhibitors, compensatory activation of parallel cell death pathways, and the absence of validated, clinically actionable biomarkers. Future efforts should therefore focus on developing cell-selective pyroptosis modulators, advanced CNS-targeted delivery platforms (e.g., nanoparticle- or antibody-conjugated systems), and biomarker-informed patient enrichment strategies to enable rational clinical translation of pyroptosis-directed therapeutics.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 29 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 5 authors, 6 keywords, 1 funder, 94 references.

Cite

This paper

Chen, Q., Yang, Y.-T., Cai, L., Zhang, H.-Q., & Yang, J. (2026). Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies. Frontiers in cell and developmental biology, 14, 1793636. https://doi.org/10.3389/fcell.2026.1793636

BibTeX

@article{chen2026pyroptosis,
author = {Chen, Qun and Yang, Yu-Tao and Cai, Li and Zhang, Hai-Qing and Yang, Juan},
title = {{Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies}},
journal = {Frontiers in cell and developmental biology},
year = {2026},
month = apr,
volume = {14},
pages = {1793636},
publisher = {Frontiers Media SA},
issn = {2296-634X},
doi = {10.3389/fcell.2026.1793636},
url = {https://doi.org/10.3389/fcell.2026.1793636},
pmid = {42111266},
pmcid = {PMC13153039}
}

RIS

TY - JOUR
AU - Chen, Qun
AU - Yang, Yu-Tao
AU - Cai, Li
AU - Zhang, Hai-Qing
AU - Yang, Juan
TI - Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies
T2 - Frontiers in cell and developmental biology
J2 - Front Cell Dev Biol
PY - 2026
DA - 2026/04/24
VL - 14
SP - 1793636
SN - 2296-634X
PB - Frontiers Media SA
DO - 10.3389/fcell.2026.1793636
UR - https://doi.org/10.3389/fcell.2026.1793636
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fcell.2026.1793636",
"type": "article-journal",
"title": "Pyroptosis in epilepsy: from pathophysiological mechanisms to therapeutic strategies",
"container-title": "Frontiers in cell and developmental biology",
"author": [
{
"family": "Chen",
"given": "Qun"
},
{
"family": "Yang",
"given": "Yu-Tao"
},
{
"family": "Cai",
"given": "Li"
},
{
"family": "Zhang",
"given": "Hai-Qing"
},
{
"family": "Yang",
"given": "Juan"
}
],
"container-title-short": "Front Cell Dev Biol",
"volume": "14",
"page": "1793636",
"DOI": "10.3389/fcell.2026.1793636",
"PMID": "42111266",
"PMCID": "PMC13153039",
"ISSN": "2296-634X",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fcell.2026.1793636",
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
24
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.heliyon.2024.e26219
Analysis of the role of PANoptosis in seizures via integrated bioinformatics analysis and experimental validation.
Journal: Heliyon
In common: NCBI GEO GSE99577, epilepsy, 2 references
[2] doi:10.1002/advs.202505778 [code]
Elevated Apolipoprotein E Expression in Hippocampal Microglia Drives Temporal Lobe Epilepsy Progression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
In common: epilepsy, cellular / molecular, 3 references
[3] doi:10.1186/s12974-024-03255-9
Myeloid gasdermin D drives early-stage T cell immunity and peripheral inflammation in a mouse model of Alzheimer's disease.
Journal: Journal of neuroinflammation
In common: cellular / molecular, 3 references
[4] doi:10.1007/s12035-025-05406-2
The Role of HIF-1α/BNIP3 Pathway in Hippocampal Neuronal Autophagy in Epilepsy.
Journal: Molecular neurobiology
In common: epilepsy, cellular / molecular, 2 references
[5] doi:10.3390/toxics14050443 [code]
6PPDQ Exposure Exacerbates Seizure-Induced Neuronal Damage via the TP53/Nrf2 Axis: An Integrated Strategy Combining Network Toxicology and Experimental Validation.
Journal: Toxics
In common: epilepsy, cellular / molecular, 2 references
[6] doi:10.3389/fimmu.2025.1616312
Identifying pyroptosis-hub genes and immune infiltration in neonatal hypoxic-ischemic brain injury.
Journal: Frontiers in immunology
In common: cellular / molecular, 2 references
[7] doi:10.1002/cns.70808
MCC-135 Exerts Antiepileptic and Neuroprotective Effects by Downregulating NCX1 Expression to Decrease Intracellular Calcium Overload in the Hippocampus.
Journal: CNS neuroscience & therapeutics
In common: epilepsy, 2 references
[8] doi:10.1073/pnas.2522313123
mtDNA leakage promotes neuron-glia crosstalk to induce epilepsy by cGAS-STING-driven neuroinflammation and serine metabolic reprogramming.
Journal: Proceedings of the National Academy of Sciences of the United States of America
In common: epilepsy, cellular / molecular, 2 references
[9] doi:10.1186/s40364-024-00636-3
Single-cell, single-nucleus and xenium-based spatial transcriptomics analyses reveal inflammatory activation and altered cell interactions in the hippocampus in mice with temporal lobe epilepsy.
Journal: Biomarker research
In common: epilepsy, cellular / molecular, 2 references
[10] doi:10.1038/s42003-026-10160-9 [code]
Low-intensity pulsed ultrasound promotes peripheral nerve regeneration by alleviating Schwann cells pyroptosis.
Journal: Communications biology
In common: cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.